Susan Hasty, Publisher
Table of Contents . . . June 6th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
Hodgkin Disease - COPP chemotherapy may prevent later hematological cancers
Leukemia - Tax protein-induced drug resistance mediated by surprising agent
Acute Myeloid Leukemia - Microenvironment rules angiogenesis in hematological cancer
Non-Hodgkin Lymphoma - New radioimmunotherapy drug proves highly effective
Stem Cell Research - Hematopoietic muscle cells originate in bone marrow
Thalassemia - Iron depletion can reverse cirrhosis in some patients given marrow transplants
Atherosclerosis - Hematopoietic stem cells may help mediate atherosclerosis
Drug Development - U.S. FTC approves global agreement signed by Isotechnika and Roche
Gaucher Disease - Monotherapy study results on Vevesca (OGT 918) presented at EWGGD
Hepatitis C - Studies: CellCept benefits patients reinfected with after liver transplant
Leukemia - Fertility affected in long-term survivors
Lymphocytic Leukemia - Campath offers new survival hope for patients with advanced B-CLL
Ovarian Cancer - Women at highest risk less likely to be screened than those at lower risk
Stem Cell Transplantation - Ganciclovir effective as human herpersvirus 6 prophylaxis
Transfusion Medicine - Warning issued over type of blood plasma; six liver transplant patients dead in Los Angeles
Transplant Medicine - Prograf plus rapamycin: Combined use safe and effective
Transplant Medicine - SangStat Medical: Rejections cut by more than half in patients treated with Thymoglobulin
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.